# Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered as Single Bolus Injections in Subjects With Stage 5 Chronic Kidney Disease on Dialysis Therapy (CKD-5D)

> **NCT01469078** · PHASE1 · COMPLETED · sponsor: **Pharmacosmos A/S** · enrollment: 18 (actual)

## Conditions studied

- Chronic Kidney Disease

## Interventions

- **DRUG:** Monofer®

## Key facts

- **NCT ID:** NCT01469078
- **Lead sponsor:** Pharmacosmos A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2012-04
- **Final completion:** 2012-11
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2012-11-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01469078

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01469078, "Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered as Single Bolus Injections in Subjects With Stage 5 Chronic Kidney Disease on Dialysis Therapy (CKD-5D)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01469078. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*